Market Overview

Citigroup Upgrades Acorda Therapeutics, Inc. to Buy, Raises PT to $33.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ACOR

DateFirmActionFromTo
Mar 2016Goldman SachsInitiates Coverage onNeutral
Jan 2016Aegis CapitalMaintainsBuy
Jun 2015GuggenheimInitiates Coverage onNeutral

View More Analyst Ratings for ACOR
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ACOR)